Not all companies are equally attractive to buyers. We identify the ten indicators that determine whether a company is sellable and what multiple it can aspire to.
After analysing hundreds of companies for potential acquisition, I have identified a clear pattern: ten indicators determine, with notable reliability, whether a company is attractive to a professional buyer and what valuation range it can aspire to.
1. Founder independence. If the company cannot function without you for three months, it is not a company — it is a job disguised as a business. Impact: 20-40% valuation reduction for founder-dependent companies.
2. Revenue recurrence. Maintenance contracts, subscriptions, stable commercial relationships. Impact: 1-2 multiple points for companies with over 70% recurring revenue.
3. Client diversification. If one client represents over 20% of revenue, that client’s loss could compromise viability. Impact: 1-2 multiple point reduction or deal rejection.
4. Stable or growing margins. Impact: premium for above-average sector margins, penalty for deteriorating margins.
5. Demonstrated growth. Consistent growth of 10%+ annually can add 1-2 multiple points.
6. Competent management team. Impact: can be the differentiating factor for a premium.
7. Documented systems and processes. Scalable and transferable versus fragile and risky.
8. Defensible competitive position. Sustainable advantages — brand, patents, location, know-how, scale.
9. Tax and legal cleanliness. Contingencies generate uncertainty that translates into discounts or deal termination.
10. Coherent results history. Five years of consistent, coherent results inspire far more confidence than erratic results regardless of how good the latest year is.
Do not wait until selling to evaluate these indicators. Review them annually. A company meeting all ten will not only be easier to sell at a better price — it will be a more solid, profitable, and pleasant company to manage.
Valuation is not an academic exercise — it is the foundation upon which the entire transaction is built. An incorrect valuation can lead to overpaying (destroying value from the outset), to unrealistic seller expectations (derailing negotiations before they begin), or to missed opportunities (walking away from companies that would have been excellent investments at a slightly different price).
The middle-market presents particular valuation challenges that do not exist in public markets or in large-cap private equity. Information is less standardised, comparables are harder to find, and the idiosyncratic characteristics of each company — founder dependence, client concentration, local market dynamics — have a disproportionate impact on value.
Moreover, the emotional dimension of valuation in the middle-market is far more intense than in institutional transactions. The seller has typically built the business over decades and has an understandable emotional attachment that does not translate neatly into financial metrics. The buyer must navigate this emotional landscape while maintaining analytical discipline.
The most reliable approach to valuation in the middle-market combines multiple methodologies, each serving as a check on the others. Transaction multiples provide a market-based reference. Discounted cash flow analysis captures the company’s specific growth and risk profile. Asset-based valuation provides a floor. And market-testing — engaging with potential buyers to gauge real interest — provides the ultimate reality check.
No single methodology is sufficient, and the art of valuation lies in synthesising insights from multiple approaches into a range that reflects both the company’s intrinsic characteristics and the market’s current appetite. At Blue Mountain, we use multiples as a starting point and then adjust — upward for companies with exceptional characteristics, downward for those with identified risks — based on deep operational analysis.
The most important quality in a valuator is intellectual honesty: the willingness to acknowledge uncertainty, to present ranges rather than point estimates, and to explain clearly the assumptions underlying any conclusion. A valuation that presents false precision is worse than one that honestly acknowledges the range of reasonable outcomes.
By Blue Mountain Capital
By Blue Mountain Capital
By Blue Mountain Capital
If you wish to explore a potential collaboration or present an investment opportunity, we invite you to contact us. We guarantee absolute confidentiality in all our conversations.